Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Journal of Cancer

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0959-8049(96)00190-6PMID 8983294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New chemotherapy agents in the treatment of advanced non-small cell lung cancer: an update including data from the Seventh World Conference on Lung Cancer.

  1995cited by this paper
• Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

  1994cited by this paper
• A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non‐Small‐Cell Lung Cancer

  1991cited by this paper
• Chemotherapy of Advanced Non‐Small-Cell Lung Cancer with Cyclophosphamide, Adriamycin, Methotrexate, and Procarbazine versus Cisplatin and Etoposide A Randomized Study

  1988cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Towards an Integration of Workflows and Clinical Guidelines: A Case Study

  2016cites this paper
• Resveratrol protects against vinorelbine-induced vascular endothelial cell injury

  2013cites this paper
• Is class III beta-tubulin a true predictive marker of sensitivity to vinorelbine in non-small cell lung cancer? Chemosensitivity data evidence.

  2011cites this paper
• Vinorelbine for non-small cell lung cancer

  2010cites this paper
• Pulmonary Resection of Non-Small Cell Lung Cancer: Is Survival in the Elderly Not Affected by Tumor Stage after Complete Resection?

  2008cites this paper
• quels patients âgés ? Cancers bronchopulmonaires non à petites cellules Non-small-cell lung cancer

  2008cites this paper
• First line oral vinorelbine in elderly patients with advanced non-small-cell lung cancer

  2007cites this paper
• Chemotherapy dose--response relationships in non-small cell lung cancer and implied resistance mechanisms.

  2007cites this paper
• Der Einfluss des Tumorsuppressorgens FHIT und des Tumoronkogens PTTG-1 auf das Überleben von Patienten mit kleinzelligem oder mit nicht-kleinzelligem Lungenkarzinom

  2006cites this paper
• Role of Non-Taxane-Containing Chemotherapy in Advanced Non-Small Cell Lung Cancer

  2006cites this paper
• Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.

  2005cites this paper
• Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence.

  2005cites this paper
• Chemotherapy for non-small cell lung cancer in elderly patients.

  2005cites this paper
• Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study.

  2005cites this paper
• Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerologie Study 9902.

  2005cites this paper
• An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer.

  2004cites this paper
• Update on the role of topotecan in the treatment of non-small cell lung cancer.

  2004cites this paper
• Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients.

  2004cites this paper
• Management of non-small cell lung cancer in elderly patients

  2004cites this paper
• Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).

  2004cites this paper
• Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer

  2004cites this paper
• Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)

  2004cites this paper
• Non-small-cell lung cancer in elderly patients: influence of age on vinorelbine oral pharmacokinetics.

  2004cites this paper
• Vinorelbine (VNR) の単剤療法

  2003cites this paper
• Single-agent chemotherapy for non-small cell lung cancer.

  2003cites this paper
• Therapiemöglichkeiten im Alter beim nichtkleinzelligen Bronchialkarzinom (NSCLC)

  2002cites this paper
• Chemotherapy of non-small cell lung cancer in elderly patients.

  2002cites this paper
• Lung Cancer in the Elderly

  2002cites this paper
• Lung cancer: a review.

  2002cites this paper
• Phase I Trial of Topotecan Plus Vinorelbine With/Without Filgrastim (G-CSF) in Patients With Refractory Malignancies

  2002cites this paper
• The role of neoadjuvant chemotherapy in marginally resectable or unresectable stage III non-small cell lung cancer.

  2002cites this paper
• Chemotherapy of non-small cell lung cancer in the elderly.

  2002cites this paper
• Therapy for stage IIIB and stage IV non-small cell lung cancer.

  2002cites this paper
• Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?

  2002cites this paper
• Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma

  2002cites this paper
• Individualized chemotherapy for elderly patients with nonsmall cell lung cancer

  2002cites this paper
• Vinorelbine in the treatment of non-small cell lung cancer.

  2002cites this paper
• Vinorelbine

  2002cites this paper
• Gemcitabine as single agent therapy in advanced non small cell lung cancer and quality of life in the elderly.

  2001cites this paper
• New directions in the treatment of non-small cell lung cancer: an overview.

  2001cites this paper
• The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.

  2001cites this paper
• Developments in cytotoxic chemotherapy: advances in treatment utilising vinorelbine.

  2001cites this paper
• Treatment of elderly patients with non-small-cell lung cancer.

  2001cites this paper
• Chemotherapy of advanced non small cell lung cancer in the elderly: an update.

  2000cites this paper
• Effect of Vinorelbine, Ifosfamide, and Cisplatin Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer

  2000cites this paper
• Is Cisplatin Required for the Treatment of Non-Small-Cell Lung Cancer? Experience and Preliminary Results of a Phase I/II Trial with Topotecan and Vinorelbine

  2000cites this paper
• Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma

  2000cites this paper
• Vinorelbine – a clinical review

  2000cites this paper
• A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancer.

  2000cites this paper
• New Drug Combinations in NSCLC: Progress in Cancer Therapy

  1999cites this paper
• Single-agent vinorelbine in the treatment of non-small cell lung cancer.

  1999cites this paper
• Vinorelbine (Navelbine) in the treatment of non-small-cell lung cancer: studies with single-agent therapy and in combination with cisplatin.

  1999cites this paper
• Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin

  1999cites this paper
• Progress in Anti-Cancer Chemotherapy

  1999influential citation
• Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.

  1999cites this paper
• Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.

  1998cites this paper
• Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.

  1997cites this paper